Dr. Douglas R. Lazzaro, MD

Dr. Lazzaro practices at NYU Faculty Group Practice in Brooklyn, New York.

Dr. Lazzaro's NPI, 1568445096, was assigned on November 29, 2005. Dr. Lazzaro graduated from State University of New York Downstate Medical Center in 1990. Dr. Lazzaro holds New York license 185979-1.

Dr. Lazzaro's primary practice is NYU Faculty Group Practice, at 7901 4th Ave, Brooklyn, NY 11209 in Kings County. The practice phone is (877) 648-2964.

Dr. Lazzaro's primary practice is NYU Faculty Group Practice in Brooklyn, New York. Dr. Lazzaro is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Lazzaro to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lazzaro practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Lazzaro's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Lazzaro is licensed in New York.

CMS data shows 2,685 Medicare services from Dr. Lazzaro across 14 procedure codes in 2024, for 932 Medicare patients. Medicare paid $169,571 for them. Every service was in an office.

CMS counts 932 Medicare patients who saw Dr. Lazzaro in 2024. The largest group is 65 to 74, with 395 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lazzaro's median patient age at 63, with 57% women.

In 2024, Dr. Lazzaro wrote 1,396 Medicare Part D claims for 342 patients. 62% of them were for generic drugs. CMS names the drug for 1,271 of them, across 22 drugs with 11 or more claims each, at $130,037 in total drug cost. In 2023, CMS named 1,109 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Lazzaro for performance year 2024, reported as part of a group. Dr. Lazzaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 24 procedures of cataract surgery by Dr. Lazzaro, more than 48% of the clinicians it reports for that procedure.

Dmand AI links 32 papers to Dr. Lazzaro, published from 2011 to 2022. 2017 was the busiest year, with 5. The most frequent topics are Retinopathy of Prematurity, Disease Models, Animal and Retina. Dr. Lazzaro has published most often in Eye Contact Lens. Dr. Lazzaro's most frequent co-authors are Gloria B. Valencia, MD, Maria B. Grant, MD and Allison Estes Rizzuti, MD.

Dmand AI links Dr. Lazzaro to 1 clinical trial. Conditions studied include Herpes Zoster Ophthalmicus and Chickenpox.

CMS Open Payments shows 42 general payments to Dr. Lazzaro from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Valeant Pharmaceuticals International paid the most, $1,500.

Dr. Lazzaro graduated from State University of New York Downstate Medical Center in 1990.